Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Depreciation and Depletion (2019 - 2020)

Avai Bio's Depreciation and Depletion history spans 3 years, with the latest figure at $14378.0 for Q4 2020.

  • For Q4 2020, Depreciation and Depletion changed N/A year-over-year to $14378.0; the TTM value through Dec 2020 reached -$14887.0, down 787.62%, while the annual FY2024 figure was $1500.0, N/A changed from the prior year.
  • Depreciation and Depletion for Q4 2020 was $14378.0 at Avai Bio, up from $14256.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $14378.0 in Q4 2020 and bottomed at -$55088.0 in Q1 2020.
  • The 3-year median for Depreciation and Depletion is $2165.0 (2018), against an average of -$1120.6.
  • The largest YoY upside for Depreciation and Depletion was 758.48% in 2020 against a maximum downside of 2644.48% in 2020.
  • A 3-year view of Depreciation and Depletion shows it stood at $2165.0 in 2018, then tumbled by 200.0% to -$2165.0 in 2019, then surged by 764.11% to $14378.0 in 2020.
  • Per Business Quant, the three most recent readings for AVAI's Depreciation and Depletion are $14378.0 (Q4 2020), $14256.0 (Q3 2020), and $11567.0 (Q2 2020).